Detalhe da pesquisa
1.
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-olds.
Clin Ther
; 39(10): 2024-2037, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923291
2.
Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine.
J Multidiscip Healthc
; 6: 249-57, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23874102